FIELD: cosmetology.
SUBSTANCE: invention relates to a polycaprolactone microsphere filler containing a polycaprolactone microsphere in an amount from 2 wt% to 50 wt%, a solution in an amount from 0.1 wt% to 5 wt%, a lubricant in an amount from 0 wt% to 48 wt.% and a pharmaceutically acceptable aqueous carrier in an amount from 15 wt.% to 97.9 wt.% from 100% of the total weight of the polycaprolactone microsphere filler, and a method for its manufacture. The polycaprolactone microsphere contains collagen peptide in an amount from 0.01 wt% to 7 wt% and has an average particle size of 10 to 100 mcm, where polycaprolactone has a viscosity increment in the range from 0.16 to 1.90 dl/g, the microsphere has a size distribution range of 1.0 or less. Also proposed is a polycaprolactone microsphere filler obtained by encapsulating a collagen peptide in polycaprolactone microspheres, which, when introduced into a living organism, demonstrates the effect of rapid collagen formation, as well as a high tissue regeneration ability, maintains the effect for a long period of time, thus demonstrating the excellent ability of soft tissues such as cheeks, breasts, nose, lips and buttocks to restore, increase volume or smooth wrinkles.
EFFECT: invention demonstrates the effect of rapid collagen formation, as well as a high tissue regeneration ability, maintains the effect for a long period of time, thus demonstrating the excellent ability of soft tissues such as cheeks, breasts, nose, lips and buttocks to restore, increase volume or smooth wrinkles.
15 cl, 3 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
POLYCAPROLACTONE MICROSPHERE FILLER CONTAINING VITAMIN C AND THE METHOD OF ITS PRODUCTION | 2019 |
|
RU2751507C1 |
PREPARATION FOR INJECTION WITH DELAYED RELEASE CONTAINING DONEPEZIL AND METHOD FOR OBTAINING SAID PREPARATION | 2018 |
|
RU2731489C1 |
METHOD OF PRODUCING BIODEGRADABLE MICROSPHERES CHARACTERIZED BY HIGH STORAGE STABILITY | 2018 |
|
RU2722358C1 |
LONG-ACTING DOSAGE FORM CONTAINING RIVASTIGMINE AND A METHOD OF ITS MANUFACTURE | 2020 |
|
RU2799939C1 |
PHARMACEUTICAL COMPOSITION CONTAINING PROLONGED RELEASE MICROSPHERES CONTAINING GPP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2834992C1 |
METHOD FOR MAKING SLOW-RELEASE MICROSPHERES WITH IMPROVED DISPERSIBILITY AND SYRINGE NEEDLE PERMEABILITY | 2007 |
|
RU2403017C2 |
RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION | 2012 |
|
RU2586306C2 |
METHOD FOR MANUFACTURE OF MICROSPHERES CONTAINING MEDICINAL SUBSTANCES AS BIOLOGICALLY ACTIVE SUBSTANCE, ENCLOSED IN POLYMER MATRIX, USING MICROSPHERES PRODUCTION BY DOUBLE EMULSION METHOD | 2016 |
|
RU2635472C1 |
SUSTAINED-RELEASE COMPOSITIONS, METHOD FOR THEIR PREPARING AND APPLICATION | 1999 |
|
RU2230550C2 |
METHOD FOR PRODUCING MICROSPHERES FOR PREPARING INJECTABLE DOSAGE FORM OF DICLOFENAC, COMPOSITION AND DOSAGE FORM | 2013 |
|
RU2524649C1 |
Authors
Dates
2021-06-17—Published
2019-01-10—Filed